🔎 Trials Near Me

Akèy › Skleroz an milti pwogresif kwonik › Kansas

Etid klinik pou Skleroz an milti pwogresif kwonik nan Kansas

4 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Kansas.

Vil nan Kansas

Tèks ofisyèl etid la (Anglè)

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  • KC Research Center, PA Neurology Research Dept, Roeland Park
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 30, 2026 · NCT07299019

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  • University of Kansas Medical Center, Kansas City
  • KC Research Center, PA Neurology Research Department, Roeland Park
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 22, 2026 · NCT07067463

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07477639

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • University of Kansas Hospital, Kansas City
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.